Similarly, elevated PLEK2 expression has been associated with enhanced invasion and metastasis in multiple cancers, including gallbladder cancer [10], non-small cell lung cancer [11], breast cancer [12], and head and neck squamous cell carcinoma (HNSCC) [13]. Here, PLEK2 is linked to breast cancer.